Table 2. Relationship between ER/PR/HER2 status and ZNF545 expression in paired breast cancer tissues.
Variable | No.paired cases | Expression rate | p-value |
ER+, PR+, HER2+ | 0.0147 | ||
Downregulation | 1 | 12.5% | |
Upregulation | 7 | 87.5% | |
ER+, PR+, HER2− | 0.0419 | ||
Downregulation | 17 | 89.5% | |
Upregulation | 2 | 10.5% | |
ER−, PR−, HER2− | 0.0252 | ||
Downregulation | 4 | 30.8% | |
Upregulation | 9 | 69.2% |